NFKB1 and prostate carcinoma: Since activation of NF-κB [24,25] and reactivation of AR signaling [26,27] are involved in prostate cancer progression and CRPC development, we reason that androgen depletion and melatonin repletion will help to prolong the progression-free survival of these patients by delaying CRPC development.